Aurobindo Pharma Limited - Disclosure under SEBI Takeover Regulations
As on :
19-Jun-2026
Aurobindo Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.